• This email address is being protected from spambots. You need JavaScript enabled to view it.

ACTG 5300/IMPAACT I2003 PHOENIx Feasibility study team. 2020.

Gupta, A., Swindells, S., Kim, S., Hughes, M.D., Naini, L., Wu, X., Dawson, R., Mave, V., Sanchez, J., Mendoza, A. and Gonzales, P., Kumarasamy, N., Comins, K., Conradie, F., Shenje, J., Fontain, S.N., Garcia-Prats, A., Asmelash, A., Nedsuwan, S., Mohapi, L., Lalloo, U.G., Ferreira, A.C.G., Mugah, C., Harrington, M., Jones, L., Cox, S., Smith, B., Shah, N.S., Hesseling, A.C., Churchyard, G.; ACTG 5300/IMPAACT I2003 PHOENIx Feasibility study team. 2020. https://academic.oup.com/cid/article-abstract/70/3/425/5426963 Clinical Infectious Diseases, 70(3), pp.425-435.


© 2025 The Aurum Institute. All Rights Reserved.